Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Accurate identification of SARS-CoV-2 T cell epitopes is vital for vaccine development and assessing cellular immunity duration.
• Previous immunoinformatics analysis identified key T cell epitopes in SARS-CoV-2 spike and nucleocapsid proteins.

Purpose of the Study:

• To evaluate 30 selected peptides for their ability to induce T cell responses and evade mutations in SARS-CoV-2 variants.
• To assess the specificity and immunogenicity of these peptides in individuals with and without prior SARS-CoV-2 exposure.

Main Methods:

• Selection of 30 SARS-CoV-2 spike and nucleocapsid-derived peptides based on immunoinformatics predictions.
• Assessment of peptide-induced T cell responses (CD4+ and CD8+) in COVID-19 recovered individuals.
• Analysis of peptide cross-reactivity in SARS-CoV-2 unexposed individuals and evaluation against mutations in variants of concern.

Main Results:

• The peptide pool demonstrated high specificity, with minimal cross-reactivity in unexposed individuals.
• Peptides were immunogenic, eliciting polyfunctional CD4+ and CD8+ T cell responses in recovered individuals.
• The identified peptides effectively avoided mutations associated with major SARS-CoV-2 variants while maintaining structural integrity.

Conclusions:

• The study identified immunogenic and specific T cell epitopes relevant for SARS-CoV-2 diagnostics.
• These epitopes are suitable for developing durable, variant-resistant vaccines that stimulate robust T cell immunity.